Catalyst Pharmaceutical Partners Inc buy Oppenheimer Holdings Inc.
Start price
27.03.24
/
50%
€15.07
Target price
27.03.25
€26.80
Performance (%)
20.38%
Price
15.08.24
€18.14
Summary
This prediction is currently active. The prediction currently has a performance of 20.38%. This prediction currently runs until 27.03.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Catalyst Pharmaceutical Partners Inc | 8.204% | 8.204% |
iShares Core DAX® | 2.821% | -1.953% |
iShares Nasdaq 100 | 5.285% | -5.092% |
iShares Nikkei 225® | 3.687% | -4.221% |
iShares S&P 500 | 3.577% | -2.240% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $29.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€14.48
06.06.24
06.06.24
€26.64
06.06.25
06.06.25
25.24%
15.08.24
15.08.24
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€14.09
21.12.23
21.12.23
€27.29
21.12.24
21.12.24
28.71%
15.08.24
15.08.24